Jeffrey I. Blankman



  • J.D., Rutgers University School of Law, Camden;
    Ph.D., Chemistry, The University of Maryland, College Park;
    B.A., Chemistry, Franklin & Marshall College.
  • Former Research & Development Scientist and Laboratory Manager for major generic Pharmaceutical Companies.

Jeff focuses his practice on patents in chemistry, materials science, textiles, medical devices and pharmaceuticals. Jeff assists clients in developing patent portfolio and prosecution strategies and provides IP evaluation and due diligence support.

More Detail:

Jeff joined Servilla Whitney in 2007 after over eight years of experience in corporate practice with large companies in the pharmaceutical industry. These include divisions of Wyeth (Formerly Wyeth-Ayerst) and Baxter Healthcare. Jeff has had roles in research organizations, advising on intellectual property matters relating to product development. Jeff’s practice centers around patent drafting and prosecution, opinions and analysis and managing intellectual property portfolios.

Jeff’s Ph.D. research at The University of Maryland focused on the electrochemical properties and electron transfer kinetics of heme proteins. Before pursuing a career in patent law, Jeff developed generic drugs as a Research and Development scientist with ESI Lederle, a division of Wyeth-Ayerst. After Baxter Healthcare purchased ESI Lederle from Wyeth, Jeff continued his scientific career as a R&D laboratory manager while attending law school.

Jeff is a member of the Pennsylvania and New Jersey bars and is registered to practice before the United States Patent and Trademark Office.

Outside the office, Jeff enjoys woodworking, golf and spending time with his family.